The immune mechanisms of acute exacerbations of idiopathic pulmonary fibrosis

被引:0
|
作者
Chen, Tao [1 ]
Sun, Wei [2 ]
Xu, Zuo-jun [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China
[2] Tianjin Med Univ, Hosp 2, Dept Resp & Crit Med, Tianjin, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
基金
中国国家自然科学基金;
关键词
acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF); immune mechanism; macrophages; Th17; acute lung injury; COLONY-STIMULATING FACTOR; REGULATORY T-CELLS; RECEPTOR-3 L412F POLYMORPHISM; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE PROGRESSION; SUPPRESSOR-CELLS; M2; MACROPHAGES; LUNG; TRANSPLANTATION; PATHOGENESIS;
D O I
10.3389/fimmu.2024.1450688
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF) are the leading cause of mortality among patients with IPF. There is still a lack of effective treatments for AE-IPF, resulting in a hospitalization mortality rate as high as 70%-80%. To reveal the complicated mechanism of AE-IPF, more attention has been paid to its disturbed immune environment, as patients with IPF exhibit deficiencies in pathogen defense due to local immune dysregulation. During the development of AE-IPF, the classical stimulatory signals in adaptive immunity are inhibited, while the nonclassical immune reactions (Th17) are activated, attracting numerous neutrophils and monocytes to lung tissues. However, there is limited information about the specific changes in the immune response of AE-IPF. We summarized the immune mechanisms of AE-IPF in this review.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis
    Invernizzi, Rachele
    Molyneaux, Philip L.
    EUROPEAN RESPIRATORY REVIEW, 2019, 28 (152):
  • [32] Effect of Acute Exacerbations of Idiopathic Pulmonary Fibrosis on Lung Transplant Outcomes
    Dotan, Y.
    Vaidy, A.
    Shenoy, K. V.
    Cordova, F. C.
    Criner, G. J.
    Mamary, A. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [33] The INPULSIS enigma: exacerbations in idiopathic pulmonary fibrosis
    Suissa, Samy
    Ernst, Pierre
    THORAX, 2015, 70 (05) : 508 - 510
  • [34] Survival in Idiopathic pulmonary fibrosis acute exacerbations: the non-steroid approach
    Spyros A Papiris
    Konstantinos Kagouridis
    Likurgos Kolilekas
    Andriana I Papaioannou
    Aneza Roussou
    Christina Triantafillidou
    Katerina Baou
    Katerina Malagari
    Stylianos Argentos
    Anastasia Kotanidou
    Anna Karakatsani
    Effrosyni D Manali
    BMC Pulmonary Medicine, 15
  • [35] Survival in Idiopathic pulmonary fibrosis acute exacerbations: the non-steroid approach
    Papiris, Spyros A.
    Kagouridis, Konstantinos
    Kolilekas, Likurgos
    Papaioannou, Andriana I.
    Roussou, Aneza
    Triantafillidou, Christina
    Baou, Katerina
    Malagari, Katerina
    Argentos, Stylianos
    Kotanidou, Anastasia
    Karakatsani, Anna
    Manali, Effrosyni D.
    BMC PULMONARY MEDICINE, 2015, 15
  • [36] Parametric Time-to-Event Model for Acute Exacerbations in Idiopathic Pulmonary Fibrosis
    Tang, Fei
    Weber, Benjamin
    Stowasser, Susanne
    Korell, Julia
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2020, 9 (02): : 87 - 95
  • [37] Factors Predicting In-Hospital Mortality in Acute Exacerbations of Idiopathic Pulmonary Fibrosis
    Guclu, Ozge Aydin
    Ozturk, Nilufer Aylin Acet
    Ozgur, Anil
    Ozpehlivan, Arzu
    Demirdogen, Ezgi
    Dilektasli, Asli Gorek
    Coskun, Funda
    Ursavas, Ahmet
    Karadag, Mehmet
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [38] Clinical trial design for acute exacerbations in idiopathic pulmonary fibrosis: A thorny path
    Renzoni, Elisabetta A.
    Wells, Athol U.
    RESPIROLOGY, 2019, 24 (07) : 620 - 621
  • [39] TIME-TO-EVENT MODEL FOR ACUTE EXACERBATIONS IN IDIOPATHIC PULMONARY FIBROSIS.
    Tang, F.
    Weber, B.
    Stowasser, S.
    Korell, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S102 - S102
  • [40] Acute exacerbations of interstitial lung disease: lessons from idiopathic pulmonary fibrosis
    Spagnolo, Paolo
    Wuyts, Wim
    CURRENT OPINION IN PULMONARY MEDICINE, 2017, 23 (05) : 411 - 417